The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of irinotecan liposome combined with 5-FU/LV + bevacizumab as first-line therapy in metastatic colorectal cancer: An early analysis from the study.
 
Meng Qiu
No Relationships to Disclose
 
Lang He
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose
 
Zhu-Mei Luo
No Relationships to Disclose
 
Yu-Zhu Zheng
No Relationships to Disclose
 
Huiting Xu
No Relationships to Disclose
 
Yongdong Jin
No Relationships to Disclose
 
Jidong Miao
No Relationships to Disclose
 
Yu Liu
No Relationships to Disclose
 
Peng Chao
No Relationships to Disclose
 
Yuwen Zhou
No Relationships to Disclose